Information  X 
Enter a valid email address

Clinigen Group PLC Ord 0.1P (CLIN)

Date Time Source Announcement
30 Jun 2020 11:00 am
RNS
Total Voting Rights
10 Jun 2020 11:00 am
RNS
Issue of Equity
05 Jun 2020 4:19 pm
RNS
Director/PDMR Shareholding
26 May 2020 2:39 pm
RNS
Update on 2019 AGM resolution vote
01 May 2020 8:00 am
RNS
Appointment of Nominated Adviser and Joint Broker
16 Apr 2020 7:00 am
RNS
Exclusive licensing agreement and trading update
24 Mar 2020 7:00 am
RNS
Purchase of shares and PDMR notification
11 Mar 2020 9:11 am
RNS
Holding(s) in Company
06 Mar 2020 7:54 am
RNS
Holding(s) in Company
28 Feb 2020 2:55 pm
RNS
Holding(s) in Company
25 Feb 2020 7:00 am
RNS
Half Year Results
04 Feb 2020 9:00 am
RNS
Notification of half year results
16 Jan 2020 7:00 am
RNS
Half Year Trading Update
14 Jan 2020 7:00 am
RNS
Agreement with Iovance to supply Proleukin?
04 Dec 2019 9:28 am
RNS
Grant of share options and PDMR notification
26 Nov 2019 10:53 am
RNS
Result of AGM
31 Oct 2019 9:46 am
RNS
Total Voting Rights
29 Oct 2019 11:18 am
RNS
Grant of share options and PDMR notification
16 Oct 2019 10:12 am
RNS
Issue of Equity
03 Oct 2019 7:00 am
RNS
Annual Report and Accounts and notice of AGM
19 Sep 2019 12:37 pm
RNS
Director/PDMR Shareholding
  7:00 am
RNS
International platform taking shape
05 Aug 2019 11:00 am
RNS
Notification of full year results date
16 Jul 2019 7:00 am
RNS
Year end trading update
28 Jun 2019 11:00 am
RNS
Total Voting Rights
26 Jun 2019 7:00 am
RNS
MHRA licenses two Melatonin products
03 Jun 2019 9:00 am
RNS
Issue of Equity
28 May 2019 6:02 pm
RNS
Holding(s) in Company
15 May 2019 7:00 am
RNS
US commercial rights of Ethyol? and Totect?
02 Apr 2019 7:00 am
RNS
Clinigen completes US Proleukin rights acquisition
29 Mar 2019 2:40 pm
RNS
Grant of share options and PDMR notification
27 Feb 2019 7:00 am
RNS
Half Year Results
25 Feb 2019 3:45 pm
RNS
Holding(s) in Company
13 Feb 2019 7:00 am
RNS
Clinigen to acquire US rights to Proleukin?
12 Feb 2019 7:00 am
RNS
Notification of half year results date
05 Feb 2019 10:00 am
RNS
Appointment of CFO
15 Jan 2019 7:00 am
RNS
Half Year trading update
30 Nov 2018 2:55 pm
RNS
Issue of Equity
28 Nov 2018 7:00 am
RNS
Capital Markets Day
15 Nov 2018 9:00 am
RNS
Board Appointment
08 Nov 2018 3:39 pm
RNS
Result of AGM
01 Nov 2018 9:52 am
RNS
Grant of Share Options and PDMR notification
31 Oct 2018 9:00 am
RNS
Total Voting Rights
09 Oct 2018 10:12 am
RNS
Clinigen Completes Acquisition of iQone Healthcare
  7:00 am
RNS
Annual Report and Accounts, and notice of AGM
02 Oct 2018 4:59 pm
RNS
Clinigen Group Completes Acquisition of CSM
01 Oct 2018 3:29 pm
RNS
Director/PDMR Shareholding
27 Sep 2018 4:37 pm
RNS
Result of Placing
  7:02 am
RNS
Clinigen acquires iQone Healthcare Holding
  7:00 am
RNS
Clinigen Group Proposed Placing up to �80m
  7:00 am
RNS
Clinigen Group agreed acquisition of CSM
  7:00 am
RNS
Final Results
07 Sep 2018 4:10 pm
RNS
Issue of Equity
31 Aug 2018 9:00 am
RNS
Notification of full year results date
25 Jul 2018 7:00 am
RNS
Clinigen acquires global rights to Imukin?
17 Jul 2018 7:00 am
RNS
Clinigen acquires global rights to Proleukin?
  7:00 am
RNS
Year end trading update
03 Jul 2018 9:25 am
RNS
Holding(s) in Company
31 May 2018 7:00 am
RNS
Extended partnership agreement signed with BMS
19 Mar 2018 7:00 am
RNS
Clinigen and Jazz Pharma initiate MA programme
 
Headlines
Top categories

03-Jul-2020 04:50 PM

Broker Forecast - Barclays Capital issues a broker note on Gamma Communications Plc

Barclays Capital today reaffirms its overweight investment rating on Gamma Communications Plc (LON:GAMA) and raised its price target to 1600p (from 15 ...

Company finder
Forthcoming announcements

a d v e r t i s e m e n t